Axogen, Inc. Common Stock vs. BioLife Solutions Inc.
BioLife Solutions Inc. (BLFS) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| AXGN | BLFS | |
|---|---|---|
| Market Cap | $2.27 billion | $1.77 billion |
| Revenue (TTM) | $251.17 million | $102.82 million |
| Net Income (TTM) | $-33,548,000 | $57.98 million |
AXGN leads on 2 of 3 size & scale factors.
Valuation
| AXGN | BLFS | |
|---|---|---|
| P/E Ratio | — | 30.60 |
| Price / Book | 8.84 | 4.21 |
| Price / Sales | 9.02 | 17.18 |
AXGN and BLFS split the valuation factors evenly.
Profitability
| AXGN | BLFS | |
|---|---|---|
| Net Margin | -13.36% | 56.39% |
| Return on Equity | -13.09% | 13.80% |
BLFS leads on 2 of 2 profitability factors.
Risk & Sentiment
| AXGN | BLFS | |
|---|---|---|
| Short Interest | 2.05% | 1.61% |
BLFS leads on 1 of 1 risk & sentiment factors.
Dig deeper: AXGN overview, AXGN financials, BLFS overview, BLFS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.